期刊
FUTURE ONCOLOGY
卷 14, 期 24, 页码 2521-2530出版社
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2018-0063
关键词
head and neck cancer; human papillomavirus; oropharyngeal cancer; otolaryngology; patient preference; radiotherapy; robotic surgical procedures; shared decision-making
类别
资金
- NIH [5T32DC000027-29]
The population of survivors with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC) is rising. The improved prognosis of this etiologic subset is reflected in new staging guidelines as well as ongoing deintensification trials aiming to preserve excellent survival while decreasing treatment-related toxicities. However, as staging criteria and treatment standards evolve in the era of transoral surgery and deintensification, little is known regarding the needs and treatment preferences of patients with HPV-OPSCC. Herein, the current knowledge regarding treatment preferences and priorities, quality of life and concerns among patients with HPV-OPSCC is reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据